850-436-6340 
Ozempic, Wegovy & Rybelsus Injury Attorneys in Austin, Texas
Ozempic, Wegovy, and Rybelsus are all popular drugs manufactured by Novo Nordisk. They belong to a class of pharmaceuticals called glucagon-like peptide-1 receptor agonists (GLP-1 RA), which share the same active ingredient: semaglutide.
Ozempic was approved by the Federal Drug Administration for use by people with Type 2 diabetes and released on the U.S. market in December 2017. With evidence that Ozempic can induce weight loss, even for those without diabetes, in 2021, the FDA approved a higher-dose version of Ozempic, sold under the brand name Wegovy, to treat obesity and for weight management. Rybelsus is designed to treat type 2 diabetes mellitus, but the medication is not injected. Instead, it is taken daily as an oral tablet.
Millions of prescriptions for Ozempic/Wegovy/Rybelsus have been filled throughout the U.S. Unfortunately, the manufacturer failed to warn its users about the potentially permanent side effects, including severe gastrointestinal problems that may impact its users’ quality of life.
Now, Ozempic, Wegovy, and Rybelsus users are pursuing Novo Nordisk for failing to disclose the risks of severe gastrointestinal conditions and other injuries caused by its use.
What Types of Gastrointestinal Problems Are Caused by Ozempic/Wegovy/Rybelsus?
Studies in the Journal of Diabetes, Obesity, and Metabolism dating back to 2017 have shown that these products’ risk of gastrointestinal problems was higher when the drug was prescribed at higher doses, for longer durations, and weight loss.
The Ozempic label mentions common adverse reactions like nausea, vomiting, diarrhea, abdominal pain, and constipation but fails to link to other side effects like:
- Cyclic Vomiting Syndrome.
- Dangerous Fluctuations in Blood Sugar Levels.
- Gallbladder Disease.
- Gallstones.
- Malnutrition.
- Nausea and Vomiting.
- Pancreatitis.
- Severe Dehydration.
- Stomach Paralysis, called Gastroparesis.
- Undigested Food Staying in the Stomach.
The primary legal issue is whether Novo Nordisk knew or should have known about the heightened risks for gastroparesis/stomach paralysis that these drugs posed to users and failed to warn doctors and patients of this risk. If you have suffered gastrointestinal injuries because of your Ozempic/Wegovy/Rybelsus use, contact our skilled personal injury attorneys in Texas today to learn more about your legal rights and options to pursue a claim.
Have the Ozempic, Wegovy & Rybelsus Warning Labels Been Updated to Include All Risks?
These drugs’ warning labels were changed in March 2022 to include a specific warning about gallbladder disease. However, before this amendment, the warning labels said nothing about gallstones or gallbladder disease, leaving patients without all the information they would need to make informed decisions about the risks of using these drugs.
Anyone who used Ozempic/Wegovy/Rybelsus before the new warning label was added and was diagnosed with gallstones, cholecystitis, or other gallbladder conditions could be entitled to financial compensation. We can help.
WE ALSO FOCUS ON THE FOLLOWING PRACTICE AREAS:
- Bicycle Accident
- Boat Accident
- Car Accident
- Civil Litigation
- Child Care
- 18 Wheeler Truck Accident
- Catastrophic Injury
- DWI Accident
- Motorcycle Accident
- PFAS & Illness Injury
- Social Media Addiction
- Workplace Injury
- Product Liability
- Pedestrian Accident
Contact Our Skilled Personal Injury Attorneys Today
Call our skilled Austin accident and injury attorneys at (512) 883-0277 or contact us online today to schedule a free consultation. With the help of our legal partners, we pursue dedicated, driven results for our clients, and there is never a charge to talk to an attorney. We stand ready to help you.
